Show
Sort by
-
Poor antibody response to BioNTech/Pfizer coronavirus disease 2019 vaccination in severe acute respiratory syndrome coronavirus 2 – naive residents of nursing homes
-
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma
-
- Journal Article
- A1
- open access
Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants
-
Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium
-
- Journal Article
- A1
- open access
The CD147 protein complex is involved in entry of Chikungunya virus and related alphaviruses in human cells
-
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
-
- Journal Article
- A1
- open access
Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine
-
Risk of misinterpretation of Ebola virus PCR results after rVSV ZEBOV-GP vaccination
-
Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in Sub-Saharan African women, with relevance to HIV risk and prevention
-
Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity